BRCA1/2 Mutation Carriers

References

• Abeliovich, D., Kaduri, L., Lerer, I., Weinberg, N., Amir, G., Sagi, M., Zlotogora, J., Heching, N., and Peretz, T., 1997. The founder mutation 185delAG and 5382insC in BRCA1 and 6174delT in BRCA2 appear in 60% of ovarian cancer and 30% of early-onset breast cancer patients among Ashkenazi women, American Journal of Human Genetics 60 (1997), pp. 505–514.
   PubMed Web of Science ®Google Scholar
• Amir, R., and Ramati, A., 2002. Post-traumatic symptoms, emotional distress and quality of life in long-term survivors of breast cancer: A preliminary research, Journal of Anxiety Disorder 16 (2002), pp. 191–206.
   Web of Science ®Google Scholar
• Antoniou, A., Pharoah, P., Narod, S., Risch, H. A., Eyfjord, J. E., Hopper, J. L., Loman, N., Olsson, H., Johannsson, O., et al., 2003. Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case series unselected for family history: A combined analysis of 22 studies, American Journal of Human Genetics 72 (2003), pp. 1117–1130.
   PubMed Web of Science ®Google Scholar
• Antonovsky, A., 1979. Health, stress and coping. San Francisco, CA: Jossey-Bass; 1979.
   Google Scholar
• Audrain, J., Schwartz, M., Lerman, C., Hughes, C., Peshkin, B. N., and Biesecker, B., 1997. Psychological distress in women seeking genetic counseling for breast-ovarian cancer risk: The contributions of personality and appraisal, Annals of Behavioral Medicine 19 (1997), pp. 370–377.
   PubMed Web of Science ®Google Scholar
• Burke, W., Daly, M., Garber, J., Botkin, J., Kahn, M. J., Lynch, P., McTiernan, A., Offit, K., Perlman, J., et al., 1997. Recommendations for follow-up care of individuals with inherited predisposition to cancer. II. BRCA1 and BRCA 2, Journal of the American Medical Association 77 (1997), pp. 997–1003.
   Google Scholar
• Carver, S. C., Scheier, M. F., and Weintraub, K. J. K., 1989. Assessing coping strategies: A theoretically based approach, Journal of Personality and Social Psychology 56 (1989), pp. 267–283.
   PubMed Web of Science ®Google Scholar
• Compas, B. E., and Luecken, L., 2002. Psychological adjustment to breast cancer, Current Directions in Psychological Science 11 (3) (2002), pp. 111–114.
   Web of Science ®Google Scholar
• Couch, F. J., DeShano, M. L., Blackwood, M. A., Calzone, K., Stopfer, J., Campeau, L., Ganguly, A., Rebbeck, T., and Weber, B. L., 1997. BRCA1 mutations in women attending clinics that evaluate the risk of breast cancer, New England Journal of Medicine 336 (1997), pp. 1409–1415.
   PubMed Web of Science ®Google Scholar
• Derogatis, L. R., 1975. Brief Symptoms Inventory. Baltimore, MD: Clinical Research; 1975.
   Google Scholar
• Gilbar, O., 1998. Coping with threat: Implications for women with a family history of breast cancer, Psychosomatics 39 (1998), pp. 329–339.
   PubMed Web of Science ®Google Scholar
• Lazarus, R. S., and Folkman, S., 1984. Stress appraisal and coping. New York: Springer Publishing; 1984.
   Google Scholar
• Lerman, C., Schwartz, M. D., and Miller, S. M., 1996. A randomized trial of breast cancer risk counseling: Interacting effects of counseling, educational level, and coping style, Health Psychology 15 (1996), pp. 75–83.
   PubMed Web of Science ®Google Scholar
• Lerman, C., Cryole, R. T., Tercyak, K. P., and Hamann, H., 2002. Genetic testing: Psychological aspects and implications, Journal of Consulting and Clinical Psychology 70 (2002), pp. 784–797.
   PubMed Web of Science ®Google Scholar
• Levy-Lahad, E., Catane, A. R., Eisenberg, S., Kaufman, B., Hornreich, G., Lishinsky, E., Shohat, M., Weber, B. L., Beller, U., et al., 1997. Founder BRCA1 and BRCA2 mutations in Ashkenazi Jews in Israel: Frequency and differential penetrance in ovarian cancer and in breast-ovarian cancer families, American Journal of Human Genetics 60 (1997), pp. 1059–1067.
   PubMed Web of Science ®Google Scholar
• Meijers-Heijboer, H., van Geel, B., van Putten, W. L., Henzen-Logmans, S. C., Seynaeve, C., Menke-Pluymers, M. B., Bartels, C. C., Verhoog, L. C., van den Ouweland, A. M., et al., 2001. Breast cancer after prophylactic bilateral mastectomy inwomen with aBRCA1or BRCA2 mutation, New England Journal of Medicine 345 (2001), pp. 159–164.
   PubMed Web of Science ®Google Scholar
• Meiser, B., and Halliday, J. L., 2002. What is the impact of genetic counselling in women at increased risk of developing hereditary breast cancer: A meta-analytic review, Social Science and Medicine 54 (2002), pp. 1463–1470.
   PubMed Web of Science ®Google Scholar
• Miki, Y., Swensen, J., and Shattuck-Eidens, D., 1994. A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1, Science 266 (1994), pp. 66–71.
   PubMed Web of Science ®Google Scholar
• Modan, B., Gak, E., Sade-Bruchim, Bar R., Hirsh-Yechezkel, G., Theodor, L., Lubin, F., Ben-Baruch, G., Beller, U., Fishman, A., et al., 1996. High frequency of BRCA1 185delAG mutation in ovarian cancer in Israel, Journal of the American Medical Association 276 (1996), pp. 1823–1825.
   Web of Science ®Google Scholar
• Oddoux, C., Struewing, J. P., Clayton, C. M., Neuhausen, S., Brody, L. C., Kaback, M., Haas, B., Norton, L., Borgen, P., et al., 1996. The carrier frequency of the BRCA2 6174delT mutation among Ashkenazi Jewish individuals is approximately 1%, Nature Genetics 14 (1996), pp. 188–190.
   PubMed Web of Science ®Google Scholar
• Offit, K., 1998. Clinical cancer genetics: Risk counseling and management. New York: John Wiley & Sons; 1998.
   Google Scholar
• Roa, B. B., Boyd, A. A., Volcik, K., and Richards, C. S., 1996. Ashkenazi Jewish population frequencies for common mutations in BRCA1 and BRCA2, Nature Genetics 14 (1996), pp. 185–187.
   PubMed Web of Science ®Google Scholar
• Rohlfs, E. M., Learning, W. G., Friedman, K. J., Couch, F. J., Weber, B. L., and Silverman, L. M., 1997. Direction detection of mutation in the breast and ovarian cancer susceptibility gene BRCA1 by PCR-mediated site-directed mutagenesis, Clinical Chemistry 43 (1997), pp. 24–29.
   PubMed Web of Science ®Google Scholar
• Rothemund, Y., Paepke, S., and Flor, H., 2001. Perception of risk, anxiety, and health behaviors in women at high risk for breast cancer, International Journal of Behavioral Medicine 8 (2001), pp. 230–239.
   Web of Science ®Google Scholar
• Struewing, J. P., Abeliovich, D., and Peretz, T., 1995. The carrier frequency of the BRCA1 185delAG mutation is approximately 1 percent in Ashkenazi Jewish individuals, Nature Genetics 11 (1995), pp. 198–200.
   PubMed Web of Science ®Google Scholar
• Struewing, J. P., Hartge, P., Wacholder, S., Baker, S. M., Berlin, M., McAdams, M., Timmerman, M. M., Brody, L. C., and Tucker, M. A., 1997. The risk of cancer associated with specific mutations in BRCA1 and BRCA2 among Ashkenazi Jews, New England Journal of Medicine 336 (1997), pp. 1401–1408.
   PubMed Web of Science ®Google Scholar
• Tavtigian, S. V., Simard, J., Rommens, J., Couch, F., Shattuck-Eidens, D., Neuhausen, S., Merajver, S., Thorlacius, S., Offit, K., et al., 1996. The complete BRCA2 gene and mutation in chromosome 13q-linked kindreds, Nature Genetics 12 (1996), pp. 333–337.
   PubMed Web of Science ®Google Scholar
• Tonin, P., Weber, B., Offit, K., Couch, F., Rebbeck, T. R., Neuhausen, S., Godwin, A. K., Daly, M., Wagner-Costalos, J., et al., 1996. Frequency of recurrent BRCA1 and BRCA2 mutations in Ashkenazi Jewish breast cancer families, Nature Medicine 2 (1996), pp. 1179–1183.
   PubMed Web of Science ®Google Scholar
• Wooster, R., Bignell, G., Lancaster, J., Swift, S., Seal, S., Mangion, J., Collins, N., Gregory, S., Gumbs, C., and Micklem, G., 1995. Identification of the breast cancer susceptibility gene BRCA2, Nature 379 (1995), p. 749.
   Web of Science ®Google Scholar
• Zimet, G. G., Dahlme, N. W., Zimet, S. G., and Farley, G. K., 1988. The multidimensional scale of perceived support, Journal of Personality Assessment 52 (1) (1988), pp. 30–41.
   Web of Science ®Google Scholar